INSMED Inc — Director's Dealing 2022

Mar 25, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2022-03-23

Reporting Person: Lewis William (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-23	Common Stock	M	30228	$14.24	Acquired	247852	Direct
2022-03-23	Common Stock	S	30228	$23.16	Disposed	217624	Direct
2022-03-23	Common Stock	M	65405	$16.16	Acquired	283029	Direct
2022-03-23	Common Stock	S	65405	$23.16	Disposed	217624	Direct
2022-03-23	Common Stock	M	981	$16.16	Acquired	218605	Direct
2022-03-23	Common Stock	S	981	$23.61	Disposed	217624	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-23	Stock Option (right to buy)	$14.24	M	30228	Disposed	2023-10-31	Common Stock (30228)	Direct
2022-03-23	Stock Option (right to buy)	$16.16	M	65405	Disposed	2026-01-07	Common Stock (65405)	Direct
2022-03-23	Stock Option (right to buy)	$16.16	M	981	Disposed	2026-01-07	Common Stock (981)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2: This is the weighted average sales price representing 30,228 shares sold at prices ranging from $22.62 to $23.61 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F3: This is the weighted average sales price representing 65,405 shares sold at prices ranging from $22.61 to $23.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F4: This is the weighted average sales price representing 981 shares sold at prices ranging from $23.61 to $23.64 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F5: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.